These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 16769867

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Nerve ischemia in Guillain-Barré syndrome: an alternative mechanism for early conduction failure.
    Berciano J, García A.
    Rev Neurol (Paris); 2002 Mar; 158(3):364-5. PubMed ID: 11976600
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. MS-275, an histone deacetylase inhibitor, reduces the inflammatory reaction in rat experimental autoimmune neuritis.
    Zhang ZY, Zhang Z, Schluesener HJ.
    Neuroscience; 2010 Aug 11; 169(1):370-7. PubMed ID: 20451583
    [Abstract] [Full Text] [Related]

  • 26. Pathophysiology of interleukin-23 in experimental autoimmune encephalomyelitis.
    Touil T, Fitzgerald D, Zhang GX, Rostami AM, Gran B.
    Drug News Perspect; 2006 Mar 11; 19(2):77-83. PubMed ID: 16628262
    [Abstract] [Full Text] [Related]

  • 27. Dendritic cells in the cerebrospinal fluid and peripheral nerves in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Press R, Nennesmo I, Kouwenhoven M, Huang YM, Link H, Pashenkov M.
    J Neuroimmunol; 2005 Feb 11; 159(1-2):165-76. PubMed ID: 15652416
    [Abstract] [Full Text] [Related]

  • 28. Expression of CD28-related costimulatory molecule and its ligand in inflammatory neuropathies.
    Hu W, Janke A, Ortler S, Hartung HP, Leder C, Kieseier BC, Wiendl H.
    Neurology; 2007 Jan 23; 68(4):277-82. PubMed ID: 17242332
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis.
    Hofstetter HH, Ibrahim SM, Koczan D, Kruse N, Weishaupt A, Toyka KV, Gold R.
    Cell Immunol; 2005 Oct 23; 237(2):123-30. PubMed ID: 16386239
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Cellular immunity in inflammatory autoimmune neuropathies.
    Mäurer M, Toyka KV, Gold R.
    Rev Neurol (Paris); 2002 Dec 23; 158(12 Pt 2):S7-15. PubMed ID: 12690655
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The critical role of IL-12p40 in initiating, enhancing, and perpetuating pathogenic events in murine experimental autoimmune neuritis.
    Bao L, Lindgren JU, van der Meide P, Zhu Sw, Ljunggren HG, Zhu J.
    Brain Pathol; 2002 Oct 23; 12(4):420-9. PubMed ID: 12408228
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Adoptive transfer-experimental allergic neuritis in newborn Lewis rats results in inflammatory infiltrates, mast cell activation, and increased Ia expression with only minor nerve fiber degeneration.
    Pilartz M, Jess T, Indefrei D, Schröder JM.
    Acta Neuropathol; 2002 Nov 23; 104(5):513-24. PubMed ID: 12410399
    [Abstract] [Full Text] [Related]

  • 38. Interleukin-18 is induced in acute inflammatory demyelinating polyneuropathy.
    Jander S, Stoll G.
    J Neuroimmunol; 2001 Mar 01; 114(1-2):253-8. PubMed ID: 11240039
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.